2019
Use of epidemiological analyses in development of colorectal cancer clinical practice guidelines in the Czech Republic
KLUGAROVÁ, Jitka, Miloslav KLUGAR, Jan MUŽÍK, Jiří JARKOVSKÝ, Radim LÍČENÍK et. al.Základní údaje
Originální název
Use of epidemiological analyses in development of colorectal cancer clinical practice guidelines in the Czech Republic
Autoři
KLUGAROVÁ, Jitka (203 Česká republika, domácí), Miloslav KLUGAR (203 Česká republika, garant, domácí), Jan MUŽÍK (203 Česká republika, domácí), Jiří JARKOVSKÝ (203 Česká republika, domácí), Radim LÍČENÍK (203 Česká republika, domácí), Petra BÚŘILOVÁ (203 Česká republika, domácí), Dana DOLANOVÁ (703 Slovensko, domácí), Martin HUNČOVSKÝ (203 Česká republika), Ladislav DUŠEK (203 Česká republika, domácí), Ivana SVOBODOVÁ (203 Česká republika, domácí), Denisa KREJČÍ (203 Česká republika, domácí) a Andrea POKORNÁ (203 Česká republika, domácí)
Vydání
International Journal of Evidence-Based Healthcare, Wolters Kluwer/Lippincott Williams & Wilkins, 2019, 1744-1609
Další údaje
Jazyk
angličtina
Typ výsledku
Článek v odborném periodiku
Obor
30230 Other clinical medicine subjects
Stát vydavatele
Spojené státy
Utajení
není předmětem státního či obchodního tajemství
Odkazy
Impakt faktor
Impact factor: 1.930
Kód RIV
RIV/00216224:14110/19:00110125
Organizační jednotka
Lékařská fakulta
UT WoS
000511111600018
Klíčová slova anglicky
clinical practice guidelines; colorectal cancer; death; diagnoses; epidemiology; survival; treatment
Příznaky
Mezinárodní význam, Recenzováno
Změněno: 11. 5. 2020 09:28, Mgr. Tereza Miškechová
Anotace
V originále
Colorectal cancer (CRC) is the third most commonly diagnosed cancer and the fourth most common cause of cancer death worldwide. Crucial in CRC as well as for other effective diagnostics and treatment is the knowledge translation and implementation of the current best available evidence into clinical practice and public health. Clinical practice guidelines are one of the useful tools to be able to improve diagnostics and increase survival rate. The epidemiological analysis was performed based on the data of the Czech National Cancer Registry from 1977 to 2017. We have analysed incidence, prevalence, mortality and primary treatment of CRC in the Czech Republic. The incidence of CRC increased significantly from 1982 to 2002 and is higher in men compared with women based on the data from the National Health Information System in the Czech Republic. The majority of the patients with CRC were diagnosed in early stages. Women were diagnosed at slightly higher age than men. An increase in surgical therapy performed in primary treatment of early CRC was reported from 2006 to 2016. Relative time of survival increased in reported patients with CRC. This analysis reported significant changes in incidence of CRC in the last 40 years as well as in diagnostics and primary therapy in early stages of CRC in the last 12 years. The first ever evidence-based clinical practice guideline on diagnostics and therapy of early CRC in the Czech Republic was developed and disseminated.